Department of Medical Sciences, Molecular Medicine


  Picture of Ann-Christine Syvanen
  (Foto: Jyrki Siikanen)
Prof. Ann-Christine Syvänen
Ann-Christine.Syvanen@medsci.uu.se
 

 

Address:

Molecular Medicine
Department of Medical Sciences
Box 1432
BMC
SE-751 44 UPPSALA

See About Us for additional contact information.

Welcome to Molecular Medicine, Department of Medical Sciences

 (Enlarge in new window)

The research group in Molecular Medicine headed by Professor Ann-Christine Syvänen was started in 1998. The group studies human diseases using modern technology for genomics.

Professor Syvänen also heads the SNP&SEQ Technology Platform that offers genotyping and next generation sequencing services and training to academic researchers. The SNP&SEQ Technology Platform is part of the genomics platform of Science for Life Laboratory in Uppsala and is also funded by the Swedish Council for Research Infrastructures (VR-RFI).

A good overview of our group can be read in a EU-publication

Use the tab-menu above to view information about our research and services.

         

News

SciLifeLab receives funds for a new Illumina HiSeqXTen sequencing system

2014-10-02

SciLifeLab is very excited to announce the receipt of a 200 million SEK gift from the Knut and Alice Wallenberg Foundation dedicated to expanding the genomics capacity in Sweden. These funds will partially be used for installing Illumina HiSeq XTen sequencers at the SNP&SEQ Technology Platform.

Publication in Science

2014-06-23

A large-scale genomic study, published in Science today, suggests that it might be the genetic make-up that make crows choose partners that look alike. The sequencing of the crows was performed by SNP&SEQ using the HiSeq platform. Read the press release here.

New R&D manager at the SEQ-platform

2014-03-01

Jessica Nordlund has joined the SNP&SEQ Technology Platform as manager for research and development.

Science for Life Laboratory joins the Illumina Genome Network

2014-02-24

Illumina announced today that Science for Life Laboratory in Sweden has joined the Illumina Genome Network to provide researchers with broader access to Illumina’s whole genome sequencing technology. Read the press release here!

VR-RFI grants funding to the SNP&SEQ Platform

2013-11-13

The Council for Research Infrastructures (VR-RFI) has granted 4.5 million SEK as support for 2014 to the SNP&SEQ Technology Platform in Uppsala. The decision corroborates the role of the SNP&SEQ Platform as a national infrastructure for Genomics. Recently, the SNP&SEQ Platform was assigned as a national infrastructure by SciLifeLab Sweden.

More HiSeq machines

2013-10-06

The Board of the National SciLifeLab has granted funding for a new HiSeq 2500 instrument to boost the sequencing capacity of the SNP&SEQ Platform. Uppsala University Hospital has granted additional funds towards a second new HiSeq 2500 instrument to be dedicated to clinical diagnostics for genetic diseases and cancer.

Large epigenetic study of acute leukemia

2013-09-24

The Molecular Medicine group, together with pediatric oncologists from several Swedish University Hospitals and hospitals in the Nordic countries, present a large epigenetic study of pediatric acute lymphoblastic leukemia, published in Genome Biology.

New publication in Nature

2013-09-15

In collaboration with several European research institutes, researchers from Molecular Medicine group and SNP&SEQ platform today present a map of genetic causes of differences between people. The study, published in Nature and Nature Biotechnology, describes the largest amount of data linking variations in the human genome with gene activity at the RNA level.